A multicentre, double-blind, amitriptyline-controIled study of mirtazapine in patients with major depression

Journal of Psychopharmacology

Volumn 10, Issue 3, 1996, Pages 235-240

  Mullin, John ^a   Lodge, Adrian ^b   Bennie, Ernest ^c   McCreadie, Robin ^d   Bhatt, Ganga Singh ^e   Fenton, George ^f  

^a De la Pole Hospital   (United Kingdom)

^b ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^c Leverndale Hospital   (United Kingdom)

^d Crichton Royal Hospital   (United Kingdom)

^e FAIRFIELD GENERAL HOSPITAL   (United Kingdom)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Amitriptyline; Antidepressants; Major depression; Mirtazapine (Org 3770)

Indexed keywords

AMITRIPTYLINE; MIRTAZAPINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; APPETITE; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SYNCOPE; THROMBOCYTOPENIA; TREMOR; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0029745693     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119601000310     Document Type: Article

References (26)

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington, DC
2. Bremner J D (In press) A double-blind comparison of Org 3770, amitriptyline and placebo in major depression. J Clin Psychiatr
3. Carney M W P, Roth M, Garside R F (1965) The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatr 111: 659-674
4. Claghorn J L, Lessem M (1995) A double-blind placebo-controlled study of Org 3770 in depressed outpatients. J Affect Dis 34: 165-171
5. 1A-mediated serotonergic neurotransmission. CNS Drugs 4 (Suppl 1): 29-38
6. 2-adrenoreceptor antagonist Org 3770 enhances serotonin transmission in vino. Eur J Pharmacol 253: R5-R6
7. 2-selective adrenoreceptor antagonist Org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission. Human Psychopharmacol Suppl 2: S107-119
8. de Montigny C, Haddjeri N, Mongeau R et al. (1995) The effects of mirtazapine on interactions between central noradrenergic and serotonergic systems. CNS Drugs 4 (suppl 1): 13-17
9. Endicott J, Spitzer R I, Fleiss J I et al. (1976) The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatr 33: 766-771
10. Goodwin F K (1994) Psychiatry. J Am Med Assoc 271: 1707-1708
11. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 23: 56-62
12. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-296
13. 3 receptors in cultured mouse neuroblastoma cells. Neuropharmacology 33: 501-510
14. Lehman E L (1975) Nonparametrics. McGraw-Hill, New York
15. Mant A, Duncan-Jones P, Saltman D et al. (1988) Development of long-term use of psychotropic drugs by general practice patients. Br Med J 296: 251-254
16. Marttila M, Jääskeläinen J, Jarvi R et al. (In press) A double-blind study comparing the efficacy and tolerability of Org 3770 and doxepin patients with major depression. Eur Neuropsychopharmacol
17. Montgomery S A, Åsberg M A (1979) A new depression rating scale designed to be sensitive to change. Br Psychiatr 134: 382-389
18. Overall J E, Gorham D (1961) The Brief Psychiatric Rating Scale (BPRS). Psychol Rep 10: 799-812
19. Richou H, Ruimy P, Charbaut J et al. (1995) A multicentre, double-blind, clomipramine-controlled efficacy and safety study of Org 3700. Human Psychopharmacol 10: 263-271
20. Ruigt G S, Kemp B, Groenhout C M et al. (1990) Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 38: 551-554
21. Sitsen J M A, Moors J (1994) Mirtazapine, a novel antidepressant, in the treatment of anxiety symptoms. Results from a placebo-controlled trial. Drug Invest 8: 339-344
22. Smith W T, Glaudin V, Panagides J et al. (1990) Mirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorder. Psychopharmacol Bull 26: 191-196
23. Spitzer R L, Endicott J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatr 53: 773-783
24. van Moffaert M, de Wilde J, Vereecken A et al. (1995) Mirtazapine is more effective than trazodone. A controlled study in hospitalised patients with major depression. Int Clin Psychopharmacol 10: 3-11
25. Vestergaard P, Gram L F, Kragh-Sorensen et al. (1993) Therapeutic potentials of recently introduced antidepressants. Psychopharmacol Ser 10: 190-198
26. Zivkov M, de Jongh G D (1995) Org 3770 vs amitriptyline: a 6-week randomised double-blind multicentre trial in hospitalised patients. Human Psychopharmacol 10: 173-180